Literature DB >> 21369795

Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease.

Renata Gonçalves Resende1, Jeane de Fátima Correia-Silva, Telma Cristina Arão, João Artur Ricieri Brito, Henrique Bittencourt, Ricardo Santiago Gomez, Mauro Henrique Nogueira Guimarães Abreu.   

Abstract

To determine the diagnostic properties of oral manifestations and histological features of graft-versus-host disease (GVHD) screening tests in the diagnosis of systemic chronic graft-versus-host disease (cGVHD). Sixty patients having undergone allogeneic haematopoietic stem cell transplantation were selected. The patients were submitted to a clinical oral examination to assess symptoms and clinical changes in the oral mucosa. Histopathologic analysis of the lower lip oral mucosa (LLOM) and salivary glands (SG) was also performed. Systemic cGVHD was used for a comparison to oral cGVHD. The accuracy of oral cGVHD tests was low for all methods (58.4% and 52.6% for white lesions and white/red lesions, respectively, in the clinical analysis; 50.4% for the presence of oral pain; and 66.8% and 55.1% for LLOM and SG histopathologic tests, respectively). However, the presence of oral pain had good diagnostic properties [specificity: 100.0, 95% confidence interval (CI): 88.0-100.0; positive predictive value (PPV): 100.0, 95% CI: 94.4-100.0; and negative predictive value (NPV): 72.0, 95% CI: 57.3-83.3]. Moreover, SG alterations revealed by the histopathological analysis also exhibited good diagnostic properties (sensitivity: 98.6, 95% CI: 81.5-99.8; PPV: 71.1, 95% CI: 62.1-79.7; NPV: 85.9 95% CI: 32.9-99.4). The clinical severity of oral lesions and histophatological changes in the LLOM did not exhibit adequate diagnostic properties, whereas both oral pain and SG histopathological analysis exhibited adequate properties for the diagnosis of systemic cGVHD. Histological changes in lip oral mucosa and salivary glands together with a clinical manifestation of the disease in the oral mucosa can be useful to determining the systemic cGVHD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369795     DOI: 10.1007/s00784-011-0529-8

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  21 in total

1.  Clinical grading of oral chronic graft-versus-host disease in 104 consecutive adult patients.

Authors:  Alessandro Busca; Franco Locatelli; Sergio Vai; Anna Maria Dall'Omo; Attilio Gargiulo; Michele Falda
Journal:  Haematologica       Date:  2005-04       Impact factor: 9.941

2.  Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  S Nakamura; A Hiroki; M Shinohara; H Gondo; Y Ohyama; T Mouri; M Sasaki; K Shirasuna; M Harada; Y Niho
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-11

3.  The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation.

Authors:  T D Horn; E B Rest; Y Mirenski; R L Corio; M L Zahurak; G B Vogelsang
Journal:  Arch Dermatol       Date:  1995-08

4.  Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.

Authors:  Jane M Fall-Dickson; Sandra A Mitchell; Susan Marden; Edward S Ramsay; Jean-Pierre Guadagnini; Tianxia Wu; Lena St John; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-06       Impact factor: 5.742

Review 5.  Oral graft-versus-host disease.

Authors:  Mark M Schubert; Maria Elvira Pizzigatti Correa
Journal:  Dent Clin North Am       Date:  2008-01

6.  Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease.

Authors:  R E Nakhleh; W Miller; D C Snover
Journal:  Arch Pathol Lab Med       Date:  1989-08       Impact factor: 5.534

7.  Vascular endothelial growth factor (VEGF) and chronic graft-versus-host disease (cGVHD) in salivary glands of bone marrow transplant (BMT) recipients.

Authors:  Leandro Napier Souza; Marcelo Antunes Carneiro; Wellington Morais de Azevedo; Ricardo Santiago Gomez
Journal:  J Oral Pathol Med       Date:  2004-01       Impact factor: 4.253

8.  [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].

Authors:  S Elad; M Levitt; Shapira M Y
Journal:  Refuat Hapeh Vehashinayim (1993)       Date:  2008-11

Review 9.  The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

Authors:  Richard M Logan; Andrea M Stringer; Joanne M Bowen; Ann S-J Yeoh; Rachel J Gibson; Stephen T Sonis; Dorothy M K Keefe
Journal:  Cancer Treat Rev       Date:  2007-05-15       Impact factor: 12.111

10.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  1 in total

1.  Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus.

Authors:  Paulo Sérgio da Silva Santos; Fábio Luiz Coracin; José Carlos de Almeida Barros; Marina Helena Cury Gallottini
Journal:  Einstein (Sao Paulo)       Date:  2014-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.